NCT05456347

Brief Summary

The aim of the study is to explore the effect of a low-calorie diet rich in protein (with a content of 35% of the total calories of the diet), mostly coming from animal sources (75% of total protein), compared to a hypocaloric diet rich in protein (with a content of 35% of the total calories of the diet), mostly coming from plant sources (75% of total proteins), in subjects with prediabetes or type 2 diabetes and overweight or obesity, on body composition, glucose and lipid metabolisms, after 6 months of intervention. To achieve the objective, a nutritional intervention study is carried out by randomizing participants to: a) a hypocaloric and high-protein diet (35% of total calories), mostly of them coming from animal sources (75% of total protein); b) a hypocaloric and high-protein diet (35% of total calories), mostly of them coming from plant sources (75% of total protein). The study has a total duration of 6 months and include the assessment of clinical, anthropometric, biochemical and lifestyle parameters, at the beginning of the study and after 3 and 6 months of intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Jul 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2021

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

July 1, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

July 13, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2022

Completed
Last Updated

November 8, 2022

Status Verified

November 1, 2022

Enrollment Period

1.3 years

First QC Date

July 1, 2022

Last Update Submit

November 6, 2022

Conditions

Outcome Measures

Primary Outcomes (7)

  • Glucose change.

    Glucose change assessed by difference in fasting glucose concentration (mg/dL and %) comparing 3 and 6 months visits with respect to baseline.

    After 3 and 6 months of intervention.

  • Glycated hemoglobin change.

    Glycated hemoglobin change assessed by difference in glycated hemoglobin concentration (%) comparing 3 and 6 months visits with respect to baseline.

    After 3 and 6 months of intervention.

  • Insulin change.

    Insulin change assessed by difference in fasting insulin concentration (UI/mL and %) comparing 3 and 6 months visits with respect to baseline.

    After 3 and 6 months of intervention.

  • HOMA-IR change.

    HOMA-IR change assessed by difference in HOMA-IR concentration (absolute units and %) comparing 3 and 6 months visits with respect to baseline. HOMA-IR is calculated by calculating: \[(fasting glucose (mg/dL) x 0,0555) x fasting insulin (UI/ml)\] ÷ 22,5.

    After 3 and 6 months of intervention.

  • Body fat mass change.

    Body fat mass change assessed by difference in fat mass (%) comparing 3 and 6 months visits with respect to baseline.

    After 3 and 6 months of intervention.

  • Fat-free mass change.

    Fat-free mass change assessed by difference in fat free-mass (%) comparing 3 and 6 months visits with respect to baseline.

    After 3 and 6 months of intervention.

  • Visceral fat mass change.

    Visceral fat mass change assessed by difference in visceral fat mass (kg and %) comparing 3 and 6 months visits with respect to baseline.

    After 3 and 6 months of intervention.

Secondary Outcomes (4)

  • Total cholesterol change.

    After 3 and 6 months of intervention.

  • LDL cholesterol change.

    After 3 and 6 months of intervention.

  • HDL cholesterol change.

    After 3 and 6 months of intervention.

  • Triglycerides change.

    After 3 and 6 months of intervention.

Other Outcomes (9)

  • C-reactive protein change.

    After 3 and 6 months of intervention.

  • Liver enzymes change.

    After 3 and 6 months of intervention.

  • Uric acid change.

    After 3 and 6 months of intervention.

  • +6 more other outcomes

Study Arms (2)

High-protein animal diet.

EXPERIMENTAL

Low-calorie and high-protein diet (35% of total calories), mostly of protein coming from animal sources (75% of total protein).

Behavioral: Low-calorie and high-protein diet with the majority of protein coming from animal sources.

High-protein vegetal diet.

EXPERIMENTAL

Low-calorie and high-protein diet (35% of total calories), mostly of protein coming from plant sources (75% of total protein).

Behavioral: Low-calorie and high-protein diet with the majority of protein coming from plant sources.

Interventions

Diet was prescribed to the participant and menus and recipes were also provided.

High-protein animal diet.

Diet was prescribed to the participant and menus and recipes were also provided.

High-protein vegetal diet.

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged between 18 and 80.
  • BMI between 27.5 kg/m2 and 40 kg/m2.
  • Diagnosed as prediabetes or type 2 diabetes according to ADA criteria.
  • Informed consent to be signed.

You may not qualify if:

  • Taking antidiabetic drugs (except for metformin with stable dose in the previous 6 months).
  • Taking lipid-lowering drugs in unstable dose in the previous 2 months.
  • Taking functional foods (i.e. sterols enriched food) or any other dietary supplement with a significant effect on lipid and glucose metabolism and body weight.
  • Uncontrolled type 2 diabetes (i.e. glycated hemoglobin over 8%)
  • Any disease that could affect study results (i.e. uncontrolled hypothyroidism).
  • Alcohol intake over 30 g/day.
  • Pregnancy or breastfeeding.
  • Any other condition that investigators consider that could interfere with study outcomes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituto de Investigación Sanitaria Aragón, Hospital Universitario Miguel Servet, Universidad de Zaragoza

Zaragoza, 50009, Spain

Location

Related Publications (1)

  • Rodrigo-Carbo C, Madinaveitia-Nisarre L, Perez-Calahorra S, Gracia-Rubio I, Cebollada A, Galindo-Lalana C, Mateo-Gallego R, Lamiquiz-Moneo I. Low-calorie, high-protein diets, regardless of protein source, improve glucose metabolism and cardiometabolic profiles in subjects with prediabetes or type 2 diabetes and overweight or obesity. Diabetes Obes Metab. 2025 Jan;27(1):268-279. doi: 10.1111/dom.16013. Epub 2024 Oct 17.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2OverweightObesityPrediabetic State

Interventions

Diet, High-Protein

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 1, 2022

First Posted

July 13, 2022

Study Start

July 1, 2021

Primary Completion

October 1, 2022

Study Completion

November 1, 2022

Last Updated

November 8, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations